(Q53917870)

22 May 2018

title

Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease. (English)

1 reference

22 May 2018

main subject

chronic liver disease

0 references

1 reference

Hatorp V

1

1 reference

22 May 2018

Walther KH

series ordinal

2

1 reference

22 May 2018

Christensen MS

series ordinal

3

1 reference

22 May 2018

Haug-Pihale G

series ordinal

4

1 reference

22 May 2018

publication date

1 February 2000

1 reference

22 May 2018

The Journal of Clinical Pharmacology

published in

1 reference

22 May 2018

volume

40

1 reference

22 May 2018

issue

2

1 reference

22 May 2018

page(s)

142-152

1 reference

22 May 2018

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

The pathogenesis of type II diabetes mellitus. A polygenic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Repaglinide: a new short-acting insulinotropic agent for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Drug administration in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Pharmacokinetics of quinine in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Diabetes mellitus and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Conjugation pathways in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Stimulation of insulin release by benzoic acid derivatives related to the non-sulphonylurea moiety of glibenclamide: structural requirements and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Drug metabolism in liver disease: implications for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

The effect of mild or moderate hepatic impairment (cirrhosis) on the pharmacokinetics of zileuton

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

The disposition of dapsone in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

In Vitro and In Vivo Study on the Conversion of Allopurinol and Pyrazinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

21 January 2018

Drugs in liver disease

1 reference

https://api.crossref.org/works/10.1177%2F00912700022008793

10.1177/00912700022008793

21 January 2018

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018